AUG 14, 2018 9:01 PM PDT

Anticancer Drugs Help Plants Fight Infection

WRITTEN BY: Nouran Amin

Image Retrieved From Unsplash, www.unsplash.com

Drugs used for cancer treatments may now help plants fight diseases. A study conducted at Washington State University (WSU), by two plant pathologists—Lee Hadwiger and Kiwamu Tanaka, has revealed that cancer-fighting drugs used on humans can help scientists examine particular biochemical pathways that will allow plants to battle infections. The study was published in the journal Frontiers in Plant Science.

The WSU Department of Plant Pathology specifically studied anticancer drugs that hold the ability to alter the DNA of cancerous cells, when used in high concentrations, in order to slow their growth or completely inhibit it. However, when these anticancer drugs were used in low concentrations in plants, they were found to change the plant cell’s DNA by turning on genes needed for defense against pathogenic invasion. These studied anticancer drugs were DNA-specific and included actinomycin D, which is also known as ‘dactinomycin’ to the pea plant (Pisum sativum).

Image Retrieved From Unsplash, www.unsplash.com

When these drugs were administered on plants, they excreted increased levels of an antimicrobial-based substance known as pisatin; a marker for a plants defense system. The treated plants were then exposed by scientists to fungal infections where the infection stopped within hours. Although Hadwiger and Tanaka, do not predict that anticancer medications will be used on crops, they do believe that this discovery brought deeper understanding onto the interactions between chemicals and plant DNA. "We used these drugs as a tool to understand how plants defend themselves from pathogens," explains Hadwiger. "We now understand how these defense genes can be activated and are using that knowledge to develop disease resistance against fungal infections and other pathogens. We needed a tool to stop the growth process in the plants and knew actinomycin D did that," Hadwiger said. "We thought we did something wrong because it didn't work at all."

Image via Phys.Org: "The effect of different concentrations of actinomycin D applied to pea tissue. The top image is lower concentration of the drug, the bottom the highest concentration." Image Credit: WSU  

 

However, when the researchers decided to administer actinomycin D on the pea plant using low concentrations, instead of the usual dose for cancer treatments, the plant was able to fight infections. "We finally figured out what was going on with the different reactions based on high and low concentrations," Hadwiger said. Since plant and animal genes are activated in the same way, it was natural to think that drugs would exert the same actions. But, researchers later found out that plant physiology handles drugs differently than in animals and humans. DNA does not readily recognize a drug as anticancer, it is just a set of compounds that is capable of alerting its makeup. "Cells only recognize the chemistry shot at them," Hadwiger explains. "We didn't expect anticancer drugs to help plants fight pathogens. But once we understood the interaction, it made sense."

The researchers of the study do not expect anyone to use anticancer medications on their crops, however, the research nonetheless is insightful. “In basic research, when you actually understand the workings or mechanisms of something, you'll be able to apply it to real-world use," Tanaka said. "We think this will have important impacts for growers that will help better fight pathogens in the near future."

 

Source: Washington State University

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
NOV 04, 2021
Immunology
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
NOV 04, 2021
Trial Flop: Experimental Asthma Treatment Makes Symptoms Worse
One causes red, scaly patches on the skin, and the other triggers breathing difficulties, but there are some common thre ...
NOV 04, 2021
Drug Discovery & Development
The first FDA approved eye drops to treat presbyopia and correct poor near-vision.
NOV 04, 2021
The first FDA approved eye drops to treat presbyopia and correct poor near-vision.
Your Grandma's favorite eyeglasses may soon find their way to the trashcan. Last Friday, October 29th, the United States ...
NOV 10, 2021
Drug Discovery & Development
Inflammation during pregnancy can affect normal brain development
NOV 10, 2021
Inflammation during pregnancy can affect normal brain development
During pregnancy the growing embryo and fetus undergo remarkable and quick developmental. Around 5 weeks after ...
NOV 19, 2021
Health & Medicine
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
NOV 19, 2021
Increase in Cannabis Use Disorder in Prenatal Hospitalizations
A recent study by Columbia University and Weill Cornell Medicine researchers found that cannabis use disorder (CUD) in p ...
NOV 30, 2021
Drug Discovery & Development
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
NOV 30, 2021
Enabling new levels of quantification with the SCIEX 7500 system - powered by SCIEX OS Software
Sensitivity is a fundamental performance characteristic of a mass spectrometer The SCIEX 7500 system is enabling new lev ...
DEC 04, 2021
Cannabis Sciences
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
DEC 04, 2021
Modulating the CBD/Apelinergic System Interaction as a COVID-19 Treatment?
Although CBD has long been implicated as an anti-inflammatory agent, it is only within the past few decades that it has ...
Loading Comments...